Morgan Stanley »

Alaunos Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Alaunos Therapeutics (TCRT) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Alaunos Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 2920002500300035004000110012001300
Value ($)Share countHistorical TCRT position of Morgan Stanley Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Alaunos Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alaunos Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.0k 1.0k 1.90
2024-09-30 $4.3k 1.3k 3.22

More positions owned by Morgan Stanley

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Morgan Stanley

Top funds holding Alaunos Therapeutics

BlackRock
Vanguard Group
Geode Capital Management
UBS Group
Citigroup
Tower Research Capital
Morgan Stanley
Advisor Group Holdings
Bnp Paribas Arbitrage, Snc
Group One Trading
Atlantic Trust
Wells Fargo & Company
Sugarloaf Wealth Management
Bank of America Corporation
Royal Bank of Canada

View all funds holding Alaunos Therapeutics